AUPH logo

Aurinia Pharmaceuticals (AUPH) Cash From Investing

Annual CFI

$39.26 M
+$45.97 M+685.48%

December 31, 2024


Summary


Performance

AUPH Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAUPHcash flowmetrics:

Quarterly CFI

$39.22 M
+$49.80 M+471.01%

December 31, 2024


Summary


Performance

AUPH Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAUPHcash flowmetrics:

TTM CFI

$39.26 M
+$45.48 M+731.42%

December 31, 2024


Summary


Performance

AUPH TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAUPHcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

AUPH Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+685.5%0.0%0.0%
3 y3 years+137.8%+178.1%+162.2%
5 y5 years+404.5%+178.1%+162.2%

AUPH Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+137.8%-20.3%+174.0%at high+137.8%
5 y5-yearat high+124.8%-20.3%+127.1%at high+118.4%
alltimeall timeat high+124.8%-54.9%+127.1%-44.6%+118.4%

Aurinia Pharmaceuticals Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2024
$39.26 M(-685.5%)
$39.22 M(-471.0%)
$39.26 M(-731.4%)
Sep 2024
-
-$10.57 M(-72.6%)
-$6.22 M(-59.5%)
Jun 2024
-
-$38.62 M(-178.4%)
-$15.35 M(-186.9%)
Mar 2024
-
$49.23 M(-886.8%)
$17.67 M(-363.5%)
Dec 2023
-$6.71 M(-88.9%)
-$6.26 M(-68.2%)
-$6.71 M(+93.4%)
Sep 2023
-
-$19.70 M(+251.3%)
-$3.47 M(-89.8%)
Jun 2023
-
-$5.61 M(-122.6%)
-$33.98 M(-297.1%)
Mar 2023
-
$24.86 M(-923.7%)
$17.25 M(-128.4%)
Dec 2022
-$60.63 M(-41.6%)
-$3.02 M(-94.0%)
-$60.63 M(-3.9%)
Sep 2022
-
-$50.22 M(-210.1%)
-$63.10 M(+38.1%)
Jun 2022
-
$45.62 M(-186.0%)
-$45.69 M(-49.0%)
Mar 2022
-
-$53.02 M(+866.2%)
-$89.64 M(-13.7%)
Dec 2021
-$103.87 M(-34.3%)
-$5.49 M(-83.3%)
-$103.87 M(+31.1%)
Sep 2021
-
-$32.81 M(-2064.4%)
-$79.24 M(-58.5%)
Jun 2021
-
$1.67 M(-102.5%)
-$190.93 M(-10.5%)
Mar 2021
-
-$67.25 M(-451.2%)
-$213.31 M(+34.8%)
Dec 2020
-$158.19 M(-2132.5%)
$19.15 M(-113.3%)
-$158.19 M(-10.8%)
Sep 2020
-
-$144.50 M(+597.7%)
-$177.36 M(+439.2%)
Jun 2020
-
-$20.71 M(+70.8%)
-$32.89 M(+299.5%)
Mar 2020
-
-$12.13 M(>+9900.0%)
-$8.23 M(-205.8%)
Dec 2019
$7.78 M(<-9900.0%)
-$29.00 K(-3.3%)
$7.78 M(-67.4%)
Sep 2019
-
-$30.00 K(-100.8%)
$23.88 M(+34.0%)
Jun 2019
-
$3.95 M(+1.6%)
$17.83 M(-25.2%)
Mar 2019
-
$3.89 M(-75.8%)
$23.85 M(<-9900.0%)
Dec 2018
-$65.00 K(-99.2%)
$16.07 M(-364.1%)
-$65.00 K(-100.1%)
Sep 2018
-
-$6.08 M(-161.0%)
$70.82 M(-987.3%)
Jun 2018
-
$9.97 M(-149.8%)
-$7.98 M(-68.0%)
Mar 2018
-
-$20.02 M(-123.0%)
-$24.98 M(+212.1%)
Dec 2017
-$8.00 M(-180.1%)
$86.96 M(-202.4%)
-$8.00 M(-91.3%)
Sep 2017
-
-$84.89 M(+1108.4%)
-$91.93 M(+1199.1%)
Jun 2017
-
-$7.03 M(+130.5%)
-$7.08 M(-277.5%)
Mar 2017
-
-$3.05 M(-200.4%)
$3.99 M(-60.1%)
Dec 2016
$9.99 M(<-9900.0%)
$3.04 M(-7884.6%)
$9.99 M(+43.7%)
Sep 2016
-
-$39.00 K(-101.0%)
$6.96 M(-0.8%)
Jun 2016
-
$4.04 M(+36.6%)
$7.01 M(+138.2%)
Mar 2016
-
$2.96 M(>+9900.0%)
$2.94 M(<-9900.0%)
Dec 2015
-$23.00 K(-99.8%)
$0.00(-100.0%)
-$23.00 K(-46.5%)
Sep 2015
-
$19.00 K(-161.3%)
-$43.00 K(-99.6%)
Jun 2015
-
-$31.00 K(+181.8%)
-$10.07 M(-0.2%)
Mar 2015
-
-$11.00 K(-45.0%)
-$10.09 M(+0.1%)
Dec 2014
-$10.08 M(>+9900.0%)
-$20.00 K(-99.8%)
-$10.08 M(+0.0%)
Sep 2014
-
-$10.01 M(>+9900.0%)
-$10.08 M(>+9900.0%)
Jun 2014
-
-$47.00 K(<-9900.0%)
-$96.00 K(0.0%)
Mar 2014
-
$0.00(-100.0%)
-$96.00 K(+166.7%)
Dec 2013
-$36.00 K(+15.4%)
-$19.00 K(-36.7%)
-$36.00 K(+34.3%)
Sep 2013
-
-$30.00 K(-36.2%)
-$26.80 K(+6600.0%)
Jun 2013
-
-$47.00 K(-178.3%)
-$400.00(-100.0%)
Mar 2013
-
$60.00 K(-712.2%)
$888.90 K(-2958.2%)
Dec 2012
-$31.20 K(-97.3%)
-$9800.00(+172.2%)
-$31.10 K(-70.7%)
Sep 2012
-
-$3600.00(-100.4%)
-$106.30 K(+115.6%)
Jun 2012
-
$842.30 K(-197.9%)
-$49.30 K(-94.6%)
Mar 2012
-
-$860.00 K(+911.8%)
-$920.20 K(-20.0%)
DateAnnualQuarterlyTTM
Dec 2011
-$1.15 M(-166.3%)
-$85.00 K(-259.2%)
-$1.15 M(+11.8%)
Sep 2011
-
$53.40 K(-286.7%)
-$1.03 M(-4.1%)
Jun 2011
-
-$28.60 K(-97.4%)
-$1.07 M(-4.3%)
Mar 2011
-
-$1.09 M(-3071.7%)
-$1.12 M(-164.6%)
Dec 2010
$1.74 M(-1162.9%)
$36.70 K(+290.4%)
$1.74 M(+5.4%)
Sep 2010
-
$9400.00(-112.2%)
$1.65 M(+8.0%)
Jun 2010
-
-$77.10 K(-104.4%)
$1.52 M(-70.3%)
Mar 2010
-
$1.77 M(-3497.5%)
$5.14 M(-3246.3%)
Dec 2009
-$163.30 K(-51.0%)
-$52.00 K(-54.0%)
-$163.40 K(-22.4%)
Sep 2009
-
-$113.10 K(-103.2%)
-$210.70 K(+35.1%)
Jun 2009
-
$3.54 M(-200.0%)
-$156.00 K(-95.9%)
Mar 2009
-
-$3.54 M(+3462.6%)
-$3.80 M(+1038.0%)
Dec 2008
-$333.60 K(-103.6%)
-$99.30 K(+70.0%)
-$333.60 K(-111.7%)
Sep 2008
-
-$58.40 K(-42.2%)
$2.85 M(-39.7%)
Jun 2008
-
-$101.10 K(+35.2%)
$4.73 M(-33.8%)
Mar 2008
-
-$74.80 K(-102.4%)
$7.14 M(-22.7%)
Dec 2007
$9.23 M(-51.5%)
$3.09 M(+69.7%)
$9.23 M(-9.6%)
Sep 2007
-
$1.82 M(-21.2%)
$10.21 M(-26.9%)
Jun 2007
-
$2.31 M(+14.4%)
$13.96 M(-14.6%)
Mar 2007
-
$2.02 M(-50.3%)
$16.36 M(-14.0%)
Dec 2006
$19.02 M(+159.5%)
$4.06 M(-27.1%)
$19.02 M(+9.5%)
Sep 2006
-
$5.57 M(+18.5%)
$17.37 M(+90.7%)
Jun 2006
-
$4.70 M(+0.4%)
$9.11 M(+23.5%)
Mar 2006
-
$4.68 M(+94.5%)
$7.38 M(+0.6%)
Dec 2005
$7.33 M(+648.1%)
$2.41 M(-189.7%)
$7.33 M(+91.5%)
Sep 2005
-
-$2.68 M(-190.3%)
$3.83 M(+30.2%)
Jun 2005
-
$2.97 M(-35.9%)
$2.94 M(-66.4%)
Mar 2005
-
$4.64 M(-523.0%)
$8.75 M(+793.1%)
Dec 2004
$979.90 K(-106.8%)
-$1.10 M(-69.3%)
$979.90 K(-108.6%)
Sep 2004
-
-$3.57 M(-140.7%)
-$11.43 M(+53.6%)
Jun 2004
-
$8.78 M(-380.1%)
-$7.44 M(-56.7%)
Mar 2004
-
-$3.14 M(-76.8%)
-$17.20 M(+19.3%)
Dec 2003
-$14.41 M(-36.1%)
-$13.51 M(-3332.7%)
-$14.41 M(-15.6%)
Sep 2003
-
$417.80 K(-142.7%)
-$17.08 M(-21.4%)
Jun 2003
-
-$978.40 K(+182.1%)
-$21.72 M(+2.4%)
Mar 2003
-
-$346.80 K(-97.9%)
-$21.22 M(-5.8%)
Dec 2002
-$22.54 M(-998.8%)
-$16.17 M(+282.9%)
-$22.54 M(+254.0%)
Sep 2002
-
-$4.22 M(+781.7%)
-$6.37 M(-1.5%)
Jun 2002
-
-$479.10 K(-71.2%)
-$6.46 M(+3.7%)
Mar 2002
-
-$1.66 M(-61.5%)
-$6.23 M(-45.9%)
Dec 2001
$2.51 M(-134.6%)
-
-
Aug 2001
-
-$4.32 M(+1634.9%)
-$11.53 M(+59.5%)
May 2001
-
-$249.00 K(+98.2%)
-$7.23 M(-0.2%)
Feb 2001
-
-$125.60 K(-98.2%)
-$7.24 M(-0.2%)
Nov 2000
-$7.25 M(+5240.8%)
-$6.84 M(>+9900.0%)
-$7.25 M(+1631.8%)
Aug 2000
-
-$16.40 K(-93.8%)
-$418.80 K(-21.9%)
May 2000
-
-$262.60 K(+90.6%)
-$536.20 K(+96.0%)
Feb 2000
-
-$137.80 K(+6790.0%)
-$273.60 K(+101.5%)
Nov 1999
-$135.80 K(+108.6%)
-$2000.00(-98.5%)
-$135.80 K(+1.5%)
Aug 1999
-
-$133.80 K(<-9900.0%)
-$133.80 K(<-9900.0%)
May 1999
-
$0.00(0.0%)
$0.00(0.0%)
Feb 1999
-
$0.00
$0.00
Nov 1998
-$65.10 K
-
-

FAQ

  • What is Aurinia Pharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals annual CFI year-on-year change?
  • What is Aurinia Pharmaceuticals quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals quarterly CFI year-on-year change?
  • What is Aurinia Pharmaceuticals TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Aurinia Pharmaceuticals?
  • What is Aurinia Pharmaceuticals TTM CFI year-on-year change?

What is Aurinia Pharmaceuticals annual cash flow from investing activities?

The current annual CFI of AUPH is $39.26 M

What is the all time high annual CFI for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high annual cash flow from investing activities is $39.26 M

What is Aurinia Pharmaceuticals annual CFI year-on-year change?

Over the past year, AUPH annual cash flow from investing activities has changed by +$45.97 M (+685.48%)

What is Aurinia Pharmaceuticals quarterly cash flow from investing activities?

The current quarterly CFI of AUPH is $39.22 M

What is the all time high quarterly CFI for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high quarterly cash flow from investing activities is $86.96 M

What is Aurinia Pharmaceuticals quarterly CFI year-on-year change?

Over the past year, AUPH quarterly cash flow from investing activities has changed by $0.00 (0.00%)

What is Aurinia Pharmaceuticals TTM cash flow from investing activities?

The current TTM CFI of AUPH is $39.26 M

What is the all time high TTM CFI for Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals all-time high TTM cash flow from investing activities is $70.82 M

What is Aurinia Pharmaceuticals TTM CFI year-on-year change?

Over the past year, AUPH TTM cash flow from investing activities has changed by $0.00 (0.00%)